Cardiology

Antiplatelets do not up recurrence in intracerebral hemorrhage

(HealthDay)—For patients with intracerebral hemorrhage, those who start antiplatelet therapy do not have an increased risk for recurrence, including those with cerebral microbleeds, according to two studies published online ...

Neuroscience

Lowering blood pressure reduces brain bleeding in strokes

The search for treatments for spontaneous intracerebral hemorrhage, the most devastating type of stroke, which carries a 40% mortality rate, has been rife with disappointments. But a new study suggests that intensive blood ...

Diseases, Conditions, Syndromes

US approves dengue vaccine Dengvaxia

US health authorities have given their approval to dengue vaccine Dengvaxia, the controversial first treatment designed to protect against the deadly mosquito-borne virus.

Diseases, Conditions, Syndromes

Congo's president wants Ebola contained within 3 months

Congo's president on Tuesday said he wants to see a deadly Ebola virus outbreak contained in less than three months even as some health experts say it could take twice as long.

Cardiology

Aggressive clearance key to best outcome after a brain hemorrhage

In the first study to identify specific surgical goals for the treatment of an intracerebral hemorrhage—the deadliest and most disabling type of stroke—a team of neurosurgeons found that at least 70 percent of the hemorrhage ...

Diseases, Conditions, Syndromes

Triazavirin defeats tick-borne encephalitis

The drug triazavirin, developed by the researchers of the Ural Branch of the Russian Academy of Sciences and the Institute of Chemical Engineering of Ural Federal University, has proved to be an effective remedy against tick-borne ...

page 11 from 30